Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent Lymphoma

NCT00954005 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
56
Enrollment
OTHER
Sponsor class

Stopped Predefined termination criterion of \> 10 patients without CR or PR was matched.

Conditions

Interventions

Sponsor

German Low Grade Lymphoma Study Group